Jun Sung Choi1, Yong Yeon Kim. 1. Department of Ophthalmology, Korea University College of Medicine, Guro Hospital, 97 Gurodong-gil, Guro-gu, Seoul 152-703, South Korea.
Abstract
PURPOSE: To determine the incidence and to characterize the risk factors of peripheral anterior synechiae (PAS) progression after laser iridotomy (LI). DESIGN: Retrospective observational cohort study. METHODS: The extents of pre- and postlaser PAS and ocular and systemic data were obtained from the charts of 54 primary angle-closure glaucoma patients (59 eyes), all of whom had undergone LI. RESULTS: PAS progressed in 19 of the 59 eyes (32.2%), during a mean follow-up period of 34.4 months (range, 6-95 months). Multivariate analysis showed that the presence of plateau iris (P = .024), and a high intraocular pressure 1 hour before LI (P = .042) were risk factors of PAS progression. CONCLUSION: Approximately one of three of the eyes showed PAS progression during a 3-year follow-up period after LI. The probability of progression was found to be higher in the eyes that exhibited plateau iris and in eyes that proved to be relatively unresponsive to medication before LI.
PURPOSE: To determine the incidence and to characterize the risk factors of peripheral anterior synechiae (PAS) progression after laser iridotomy (LI). DESIGN: Retrospective observational cohort study. METHODS: The extents of pre- and postlaser PAS and ocular and systemic data were obtained from the charts of 54 primary angle-closure glaucomapatients (59 eyes), all of whom had undergone LI. RESULTS:PAS progressed in 19 of the 59 eyes (32.2%), during a mean follow-up period of 34.4 months (range, 6-95 months). Multivariate analysis showed that the presence of plateau iris (P = .024), and a high intraocular pressure 1 hour before LI (P = .042) were risk factors of PAS progression. CONCLUSION: Approximately one of three of the eyes showed PAS progression during a 3-year follow-up period after LI. The probability of progression was found to be higher in the eyes that exhibited plateau iris and in eyes that proved to be relatively unresponsive to medication before LI.
Authors: Roland Y Lee; Toshimitsu Kasuga; Qi N Cui; Guofu Huang; Mingguang He; Shan C Lin Journal: Invest Ophthalmol Vis Sci Date: 2013-05-01 Impact factor: 4.799
Authors: Yan Yun Chen; Su Jie Fan; Yuan Bo Liang; Shi Song Rong; Hai Lin Meng; Xing Wang; Ravi Thomas; Ning Li Wang Journal: J Ophthalmol Date: 2017-09-01 Impact factor: 1.909